CPIG
AST

Chicago Partners Investment Group’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Chicago Partners Investment Group’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-16
Closed – – 1097
2018
Q3 		$0 Hold
16
– – ﹤0.01% 1130
2018
Q2 		$0 Hold
16
– – ﹤0.01% 1027
2018
Q1 		$0 Hold
16
– – ﹤0.01% 966
2017
Q4 		$0 Hold
16
– – ﹤0.01% 1001
2017
Q3 		$0 Buy
+16
New +$54 ﹤0.01% 1012
2017
Q2 		– Sell
-16
Closed – – 859
2017
Q1 		$0 Hold
16
– – ﹤0.01% 623
2016
Q4 		$0 Hold
16
– – ﹤0.01% 578
2016
Q3 		$0 Hold
16
– – ﹤0.01% 512
2016
Q2 		$0 Hold
16
– – ﹤0.01% 468
2016
Q1 		$0 Hold
16
– – ﹤0.01% 513
2015
Q4 		$0 Hold
16
– – ﹤0.01% 533
2015
Q3 		$0 Hold
16
– – ﹤0.01% 473
2015
Q2 		$0 Buy
+16
New +$153 ﹤0.01% 514

Other funds holding AST

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chicago Partners Investment Group's AST Position: Q4 2018 in Review

Chicago Partners Investment Group sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q4 2018, closing a stake of 16 shares.

Chicago Partners Investment Group first reported a position in AST in Q2 2015 and held it in 13 quarters. The position peaked at $0 in Q3 2018. 46 funds tracked by Wall St. Rank hold AST as of Q4 2018.

  • Chicago Partners Investment Group reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q4 2018 after selling out during the quarter.
  • Chicago Partners Investment Group sold 16 Asterias Biotherapeutics Inc. Series A shares in Q4 2018.
  • Chicago Partners Investment Group first reported a position in Asterias Biotherapeutics Inc. Series A in Q2 2015 and held it in 13 quarters.
  • Chicago Partners Investment Group's Asterias Biotherapeutics Inc. Series A position peaked at $0 in Q3 2018.
  • 46 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q4 2018.

Based on Chicago Partners Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.